Overview
Status
Active
Registry date
2023-06-20
Share capital
5 000,00 PLN
Registered address
ul. Giełdowa 5, 01-211 Warszawa, Poland
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 11.54mMedianUSD 125.45kAverageUSD 2.35m
Net profit
This companyUSD 386.46kMedianUSD 4.18kAverageUSD 84.12k
Operating costs
This companyUSD 10.79mMedianUSD 115.22kAverageUSD 2.08m
Assets
This companyUSD 6.22mMedianUSD 85.81kAverageUSD 2.26m
Industry
Bank accounts
Registered as a VAT taxpayer on 2023-07-03. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
James Alexander Konstanczak — Attorney-in-fact (sole)
Katherine Miller Hottmann — Management Board Member
Bogdan Wojciechowski — Attorney-in-fact (sole)
Bradley Jay Slater — Management Board Member
Ewelina Jankowska — Attorney-in-fact (sole)
Manner of representation
Each member of the management board is authorised to represent the company, make declarations and sign on behalf of the company, acting independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Genomic Health, Inc. | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bradley Jay Slater (57) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
James Russell Wenner (59) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| B2 ImpactS.A. | $34,195,484.61 | b2-impact.pl | ||
| Sfinks PolskaS.A. | $13,410,597.69 | sfinks.pl | ||
| Authologicsp. z o.o. | $1,686,995.38 | authologic.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-07-10 | Address change (Ul. Taśmowa 7b, 02-677, Warszawa → Ul. Giełdowa 5, 01-211, Warszawa) | |
| 2024-12-14 | PKD change (Removed: 62.01.Z, 62.02.Z, 62.03.Z, 62.09.Z, 70.21.Z, 73.11.Z, 74.90.Z; Added: 46.19.Z, 46.46.Z, 72.11.Z, 72.19.Z, 78.10.Z, 82.20.Z, 86.90.E) | |
| 2024-01-17 | Address change (Ul. Towarowa 28, 00-839, Warszawa → Ul. Taśmowa 7b, 02-677, Warszawa) | |
| 2024-01-12 | Name change (Bovtestille Investments → Exact Sciences Poland) | |
| 2024-01-12 | PKD change (Removed: 41.10.Z, 41.20.Z, 47.91.Z, 64.20.Z, 64.92.Z, 68.10.Z, 68.20.Z, 68.32.Z, 70.10.Z; Added: 62.01.Z, 62.02.Z, 62.03.Z, 62.09.Z, 63.11.Z, 70.21.Z, 73.11.Z, 74.90.Z, 82.99.Z) |
FAQ
The main business activity of Exact Sciences Poland focuses on business support activities n.e.c..
The company was registered in the Polish National Court Register (KRS) on June 20, 2023.
The headquarters is located at: ul. Giełdowa 5, 01-211 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of USD 11,543,415, representing an increase of 181.2% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of USD 386,461, meaning the company increased its profit by 348.3%.
The largest operating cost category falls under employee remuneration. This category amounted to USD 4,908,102 in 2025, representing 45% of all operating expenses.
Last updated: 2026-09-22
